Key facts
- CVS Health reported strong second-quarter results.
- The company raised its 2026 profit forecast to $7.90-$8.10 per share.
- CVS Health provided a 2027 profit outlook of at least $8.44 per share.
- CVS Health shares fell nearly 6% after the announcement.
CVS Health reported better-than-expected second-quarter results, driven by a more profitable drug mix and bonus payments for its government health plans. This performance led the company to raise its 2026 profit forecast to between $7.90 and $8.10 per share. However, the company's outlook for 2027, set at a minimum of $8.44 per share, was described as tepid. This guidance overshadowed the positive quarterly results, causing CVS Health shares to fall nearly 6%. The stock initially jumped on the earnings beat but reversed sharply lower, with management's 2027 outlook cited as a potential trigger for the decline. The company also announced $29 appointments for weight-loss drug prescriptions at its MinuteClinic.